Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 121

Results For "data"

1569 News Found

Biohaven and Pfizer announce positive topline results of rimegepant to treat migrane
Biotech | February 14, 2022

Biohaven and Pfizer announce positive topline results of rimegepant to treat migrane

Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific


X-Chem and Excelra's GOSTAR team up to discover drugs for challenging targets
Digitisation | February 10, 2022

X-Chem and Excelra's GOSTAR team up to discover drugs for challenging targets

GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study. X-Chem's RosalindAI delivered superior and actionable results than other similar analyses using well-known publically available datasets


USFDA awards QIDP designation for prevention of chlamydia to Evofem Biosciences
Drug Approval | February 10, 2022

USFDA awards QIDP designation for prevention of chlamydia to Evofem Biosciences

Adds five years of market exclusivity on approval


Gamida Cell initiates rolling submission of Biologics License Application for Omidubicel
Biotech | February 10, 2022

Gamida Cell initiates rolling submission of Biologics License Application for Omidubicel

On track to complete the BLA submission in the first half of 2022


Scientists breaking barriers to treating heart failure
Medical Device | February 09, 2022

Scientists breaking barriers to treating heart failure

Cysoni is a bionic device that paces the heart with real-time respiratory modulation. The innovation stems from the idea that heart rate increases and decreases with each breath in normal physiology, termed ‘respiratory sinus arrhythmia’ (RSA)


Wockhardt gets CDSCO nod to export 100 million doses of Sputnik vaccines
News | February 08, 2022

Wockhardt gets CDSCO nod to export 100 million doses of Sputnik vaccines

Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against Covid-19


AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.
News | February 08, 2022

AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.

Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021


India grants Emergency Use Authorisation to Sputnik Light
News | February 07, 2022

India grants Emergency Use Authorisation to Sputnik Light

This is the ninth Covid-19 vaccine approved in India


Expert panel recommends Emergency Use Authorisation for Sputnik Light
News | February 05, 2022

Expert panel recommends Emergency Use Authorisation for Sputnik Light

The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval


Thermo Scientific launches Nicolet RaptIR FTIR microscope
Medical Device | February 04, 2022

Thermo Scientific launches Nicolet RaptIR FTIR microscope

New instrument helps maximize lab productivity and extends FTIR to large, heavy samples